EGFR and adenocarcinoma: These patterns (I and II) were distinguished by a significantly higher EGFR mutation rate (p < 0.001), proportion of females (p < 0.001), adenocarcinomas (p < 0.001), and never smokers (p < 0.001) in pattern II for both the training and validation cohorts.